Graph-DTI: A new Model for Drug-target Interaction Prediction Based on Heterogenous Network Graph Embedding

Author:

Qu Xiaohan1,Du Guoxia1,Hu Jing1,Cai Yongming1

Affiliation:

1. Guangdong Pharmaceutical University

Abstract

Abstract Background Accurate prediction of drug-target interactions (DTIs) can guide the drug discovery process and thus facilitate drug development. Most existing computational models for machine learning tend to focus on integrating multiple data sources and combining them with popular embedding methods. However, researchers have paid less attention to the correlation between drugs and target proteins. In addition, recent studies have employed heterogeneous network graphs for DTI prediction, but there are limitations in obtaining rich neighborhood information among nodes in heterogeneous network graphs. Results Inspired by recent years of graph embedding and knowledge representation learning, we develop a new end-to-end learning model, called Graph-DTI, which integrates various information from heterogeneous network data and automatically learns topology-preserving representations of drugs and targets to facilitate DTI prediction. Our framework consists of three main building blocks. First, we integrate multiple data sources of drugs and target proteins and build a heterogeneous network from a collection of datasets. Second, the heterogeneous network is formed by extracting higher-order structural information using a GCN-inspired graph autoencoder to learn the nodes (drugs, proteins) and their topological neighborhood representations. The last part is to predict the potential DTIs and then send the trained samples to the classifier for binary classification. Conclusions The substantial improvement in prediction performance compared to other baseline DTI prediction methods demonstrates the superior predictive power of Graph-DTI. Moreover, the proposed framework has been successful in ranking drugs corresponding to different targets and vice versa. All these results suggest that Graph-DTI can provide a powerful tool for drug research, development and repositioning.

Publisher

Research Square Platform LLC

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3